New-Gen EVAR Tech Should Allay Concerns Over Not-So-Favorable New Data
This article was originally published in Clinica
New data on the long-term clinical benefits of endovascular aortic repair (EVAR) have put the minimally invasive technique in a less than favorable light. However, these findings are not expected to dent the market for these devices as continued improvements in newer-generation EVAR systems, such as Medtronic’s Endurant, appear successful in countering the technology’s known shortcomings.
Register for our free email digests: